Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SMMT

Summit Therapeutics Inc

May 29 • 04:00PM ET

17.54

+0.13 0.75 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: EXEL MRNA REGN VRTX BMRN INCY IONS ALNY GILD AMGN

| Held by: XBI VTI VB VXF VBR IBB IWP VHT IWF IWR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.60	Insider Own	82.66%	Shs Outstand	776.02M	Perf Week	0.40%
Market Cap	13.60B	Forward P/E	-	EPS next Y	-1.13	Insider Trans	0.00%	Shs Float	134.46M	Perf Month	-15.79%
Enterprise Value	13.02B	PEG	-	EPS next Q	-0.28	Inst Own	15.54%	Short Float	22.18%	Perf Quarter	5.73%
Income	-1.21B	P/S	-	EPS this Y	21.47%	Inst Trans	1.25%	Short Ratio	8.20	Perf Half Y	-0.57%
Sales	0.00M	P/B	24.93	EPS next Y	-0.10%	ROA	-233.81%	Short Interest	29.82M	Perf YTD	0.29%
Book/sh	0.70	P/C	22.70	EPS next 5Y	28.53%	ROE	-270.95%	52W High	30.98 -43.38%	Perf Year	-33.08%
Cash/sh	0.77	P/FCF	-	EPS past 3/5Y	-52.45% -13.76%	ROIC	-214.31%	52W Low	13.83 26.83%	Perf 3Y	963.03%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.93% 6.86%	Perf 5Y	124.30%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-384.68%	Oper. Margin	-	ATR (14)	1.31	Perf 10Y	109.31%
Dividend Ex-Date	-	Quick Ratio	7.41	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	46.70	Recom	1.94
Dividend Gr. 3/5Y	- -	Current Ratio	7.41	EPS Q/Q	-186.74%	SMA20	0.72%	Beta	-1.32	Target Price	28.51
Payout	-	Debt/Eq	0.04	Sales Q/Q	-	SMA50	-7.69%	Rel Volume	1.98	Prev Close	17.41
Employees	265	LT Debt/Eq	0.03	Earnings	Apr 30 AMC	SMA200	-6.50%	Avg Volume	3.64M	Price	17.54
IPO	Mar 05, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.85% -100.00%	Trades		Volume	7,202,435	Change	0.75%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)